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Background: The left atrial volume index (LAVI), measured at end-systole (largest atrial volume), has been shown to be a strong predictor of 
cardiovascular outcomes. We hypothesized that left atrial residual volume index (LARVI), measured at end-diastole (smallest atrial volume), would 
have better predictive value.
Methods: The Heart and Soul Study was a prospective cohort study of psychosocial factors and health outcomes in ambulatory adults with stable 
coronary artery disease. We measured the LARVI and LAVI in 938 subjects without atrial fibrillation or flutter or significant mitral valve disease. 
Outcomes assessed were heart failure (HF) hospitalizations, myocardial infarction (MI), stroke, heart disease death, a composite cardiovascular (CV) 
outcome consisting of these four outcomes, and all-cause mortality. Logistic regression models were used to calculate odds ratios (OR) adjusted for 
demographic, clinical, and echocardiographic parameters.
Results:  Mean values were 67±11 years for age, 14.7±7.6 ml/m2 for LARVI, 32.0±10.6 ml/m2 for LAVI, and 62±10% for left ventricular ejection 
fraction. There were 147 HF hospitalizations, 118 MIs, 45 strokes, 96 heart disease deaths, and 351 total deaths at 7.3±2.6 years follow-up. In 
unadjusted data, the c-statistics for LARVI were 0.70 for HF hospitalizations, 0.62 for the composite CV outcome, and 0.59 for total death compared 
to 0.68, 0.59, and 0.58, respectively, for LAVI. In the multivariable adjusted model, comparing the highest quartile of LARVI (starting at 18.5 ml/m2) 
to the remainder of the quartiles, the OR was 3.03 (1.78-5.13, p<0.0001) for HF hospitalizations, 2.21 (1.41-3.44, p<0.0001) for the composite CV 
outcome, and 1.60 (1.04-2.46, p=0.033) for total death. For LAVI, when comparing the highest quartile (starting at 38.4 ml/m2) to the remainder 
of the quartiles, the adjusted OR was 1.44 (0.84-2.46, p=0.18) for HF hospitalizations, 1.28 (0.82-2.00, p=0.29) for the composite CV outcome, 
and 1.47 (0.96-2.25, p=0.08) for total death.
Conclusions: In ambulatory adults with stable coronary artery disease, the left atrial residual volume index is a better predictor of cardiovascular 
events than the standard left atrial volume index.
